These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 17684018)
1. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog. Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928 [TBL] [Abstract][Full Text] [Related]
3. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Yan X; Fraser M; Qiu Q; Tsang BK Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436 [TBL] [Abstract][Full Text] [Related]
4. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance. Singh M; Chaudhry P; Fabi F; Asselin E BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432 [TBL] [Abstract][Full Text] [Related]
7. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411 [TBL] [Abstract][Full Text] [Related]
8. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells. Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635 [TBL] [Abstract][Full Text] [Related]
9. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644 [TBL] [Abstract][Full Text] [Related]
10. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch. Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. Selvendiran K; Kuppusamy ML; Bratasz A; Tong L; Rivera BK; Rink C; Sen CK; Kálai T; Hideg K; Kuppusamy P J Pharmacol Exp Ther; 2009 Jun; 329(3):959-66. PubMed ID: 19276401 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation. Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736 [TBL] [Abstract][Full Text] [Related]
13. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. Yang CH; Yue J; Sims M; Pfeffer LM PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701 [TBL] [Abstract][Full Text] [Related]
14. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma. Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770 [TBL] [Abstract][Full Text] [Related]
15. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917 [TBL] [Abstract][Full Text] [Related]
16. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001 [TBL] [Abstract][Full Text] [Related]
17. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells. Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500 [TBL] [Abstract][Full Text] [Related]
18. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway. Chen Q; Qin R; Fang Y; Li H Cell Physiol Biochem; 2015; 36(3):956-65. PubMed ID: 26087719 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related]
20. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Weir NM; Selvendiran K; Kutala VK; Tong L; Vishwanath S; Rajaram M; Tridandapani S; Anant S; Kuppusamy P Cancer Biol Ther; 2007 Feb; 6(2):178-84. PubMed ID: 17218783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]